New Thread

Ctrl

I

ProShares UltraShort Health Care Stock Price: Quote, Forecast, Splits & News (RXD)

Perplexity Finance

/

Company Profile

ProShares UltraShort Health Care Price & Performance (RXD)

Stock Performance

Updated Apr 25, 7:53 PM UTC

ProShares UltraShort Health Care

$11.69USD

-$0.11 (-0.89%)

Open

$11.85

Market Cap

$1.37M

Year High

$13.40

High

$11.85

P/E Ratio

Year Low

$9.11

Low

$11.69

Dividend Yield

3.93%

Volume

2.27K

What's Happening

Peers

ProShares UltraShort Consumer Goods
$11.92
SZK:AMEX
0.66%
ProShares UltraShort Utilities
$15.32
SDP:AMEX
0.73%
ProShares UltraShort Industrials
$8.32
SIJ:AMEX
ProShares UltraShort Technology
$11.03
REW:AMEX
2.88%
ProShares UltraShort Consumer Services
$10.92
SCC:AMEX
3.53%

Related

Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. · See all tickers.

Overview
Latest News
Earnings
Related

Go Deeper

How might the recent rally in health care stocks, driven by easing trade tensions, impact the short-term performance of RXD, which profits from sector declines?
With diagnostics and biotech subsectors underperforming, will RXD benefit further if these trends continue or worsen in the near future?
Given RXD's negative performance and high expense ratio, are there upcoming regulatory or sector risks that could reverse its fortunes?
How could the divergence between outperforming medical distribution/retail and lagging biotech/diagnostics affect RXD’s volatility and returns?
What are the implications of the recent quarterly distribution for RXD investors amid a challenging sector outlook?

Latest News

ProShares Expands Crypto ETF Lineup With XRP Futures Funds Launching April 30
Apr 22, 2025
ProShares will introduce three XRP futures-based ETFs at the end of April, reflecting growing institutional interest in the cryptocurrency. This move follows the strong debut of the Teucrium 2x Long Daily XRP ETF and comes amid rising U.S. spot trading volumes for XRP, signaling increasing market maturity and anticipation for a spot ETF approval.12
Institutional Signals Indicate Strong Short-Term Momentum for ProShares UltraShort Health Care (RXD)
Apr 22, 2025
AI-driven analysis and technical indicators show ProShares UltraShort Health Care (RXD) maintaining strong near- and mid-term ratings, with real-time triggers available for institutional traders. The ETF, designed to profit from declines in the healthcare sector, continues to attract attention as proprietary models highlight volatility and potential trading opportunities.32
Quarterly Dividend Announced for ProShares UltraShort Health Care ETF
Mar 26, 2025
ProShares UltraShort Health Care (RXD) has declared a quarterly distribution of $0.06553 per share, payable April 1 for shareholders of record as of March 26. The ETF, which seeks to deliver twice the inverse daily performance of the healthcare sector, continues to provide regular income for investors despite recent market fluctuations.45